Buy & Sell Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 (SLVO) – Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 Price Today
Key Stats
- -Market Cap
- Income / Options OverlaySector
- -20.89%3M Drawdown
- -Enterprise Value
- -Dividend Yield
- 12 daysTypical Hold Time
Over the past 52 weeks, Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 has traded between a low of $77.2 and a high of $107.41, highlighting its annual price range. Over the past three months, Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 has recorded a drawdown of -20.89%, reflecting recent price volatility. On average, investors hold Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033 for approximately 12 days, indicating typical investor behavior on the platform.
About Ubs Ag Etracs Silver Shares Covered Call ETN Exp 21 Apr 2033
SLVO is an exchange-traded note issued by UBS AG that provides investors with exposure to the performance of a silver-based covered call strategy. The ETN tracks the daily return of the ISE Enhanced 100x Leveraged Silver ETN Index, which combines a long position in silver with a covered call strategy on the silver position. This strategy aims to generate current income from the option premiums, which can provide a buffer during sideways or slightly down markets for silver, but it also caps the potential gains from a significant rise in silver prices. As an ETN, it is subject to the credit risk of the issuer, UBS AG, and has an expiration date of April 21, 2033.
Most Recent News
Whitehawk reveals SEZ6 as a promising target for new cancer drug HWK-206, advancing to clinical trials in 2026.
Whitehawk Therapeutics announced data showing SEZ6 protein is highly expressed in small cell lung cancer (SCLC) and other neuroendocrine tumors, exceeding other known targets. This supports their development of HWK-206, a next-generation antibody dru...
PAPZIMEOS shows 83% durable response in RRP patients with FDA granting 7-year market exclusivity
Precigen's PAPZIMEOS, the first FDA-approved therapy for recurrent respiratory papillomatosis (RRP), demonstrated durable complete responses in 83% of patients over at least 36 months without additional treatment. Five patients maintained responses b...
AI crypto sector nears $26.6B as Ruvi AI launches major upgrade and unique token burn model.
The AI cryptocurrency sector reached a market cap of about $26.6 billion in May 2026, led by projects like Chainlink and NEAR Protocol. Ruvi AI (RUVI) stands out by integrating over 20 AI models into a decentralized platform that rewards contributors...